Академический Документы
Профессиональный Документы
Культура Документы
Dr. Rao Papineni : Imaging in vivo ROS Activity in Inflammation and Cancer
Venue:
19 - 21 December, 2012
Topics to be addressed :
(a) Application of Emerging Technologies in Cancer Research (b) Genetic and Epigenetic Mechanisms in the Pathobiology of Cancer (c) Novel Therapies (Immuno-and Stem Cell-based Therapies) (d) Complementary and Alternative Approaches for Cancer Prevention and Therapy Organizing Committee (USA) Sushanta K. Banerjee (Chair) C.V.Rao ,(Co-Chair) Rajesh Agarwal , (Co-Chair) Shivendra Singh , (Co-Chair) Organizing Committee (India) Dhrubajyoti Chattopadhyay (Chair) Gopal Kundu (Co Chair) Bhudev C Das (Co-Chair) Secretaries Organizing Committee Gaurisankar Sa (Secretary) Urmi Chatterji (Secretary) Treasurer Alok Kumar Sil
Contact
USA INDIA
3rd International Cancer Research Symposium 2012 Defining & Translating Science for Disease Prevention and Therapy
19-21 December, 2012
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat Kolkata, West Bengal 700157, India
The Registration Fee (along with the Registration Form) has to be paid as follows: Payment through Demand Draft, multicity account payee cheque or Money Transfer / National Electronic Fund Transfer (NEFT/RTGS) only. Demand draft or multicity account payee cheque should be drawn in favour of 3rd ICRS 2012 payable at Kolkata (Registration will be confirmed after realization of cheques). Money transfer/NEFT/RTGS (Inter-Bank Transfer): State Bank of India, Calcutta University Branch, IFSC Code SBIN0007766, A/C No. 32470598175. Money transfer can also be done through Internet Banking. Wire transfer for Foreign Remittance through SWIFT Code SBININBB106 Please write your name and address on the back of the Bank Draft without fail and also enclose three stamp size photographs
3rdicrs.2012@gmail.com
(presenting authors name underlined), place of work, contact telephone number and email address. The abstract should have an Introduction, Material and Methods, Results and a Conclusion Section. The authors should indicate in the registration form whether they prefer to make a Poster or Oral presentation.
ABSTRACTS should be 2000 characters or less with space and have a title, authors names
Director, Centre for Research in Nanoscience and Nanotechnology JD-2, Sector-III, Salt Lake, Kolkata-700 098, West Bengal Telephone : +91 +033-2335 0067 / Fax : +91 +033-2257 1470 E-mail: 3rdicrs.2012@gmail.com Website : http://www.3rdicrs2012.org
Prof. D. J. Chattopadhyay
3rd International Cancer Research Symposium 2012 Defining & Translating Science for Disease Prevention and Therapy
19-21 December, 2012
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata, West Bengal 700157, India
Prefix Prof./ Dr./ Mr./ Ms. First name, Surname Gender Department Institution Address City PIN FAX Nationality
Registration 15 October, 2012 Spot registration
Faculty/ Clinician
Scholar
Male
Female
Country Cell #
Foreign
Faculty and Clinicians Rs. 3,000 Rs. 5,000
Category of Participation
Invited Speaker
Young Scientist
Delegate
General
YES VEG
NO
POSTER
cv
TITLE SPEAKER
1. Addanki Pratap Kumar , Ph.D (USA) Translation of complementary and alternate
*(TBA-to
2. Adhip N Majumdar, Ph.D. (USA) Cancer Stem Cells: Implications for Colorectal Carcinogenesis and Development of Therapeutic Strategies
3.
Ajay Rana, Ph.D. (USA) Mixed Lineage Kinases: Novel Therapeutic Targets of Proliferative and Degenerative Diseases
5. Alo Nag, Ph.D. (IND) Combating Cancer Through Discovery of Novel Molecular Targets.
7.
8. Andrew Leask, Ph.D. (CAN) Managing the microenvironment: matricellular adhesive proteins as signaling modulators in skin
9.
of
Vegetable-Derived
Chemopreventive Agent
Developing therapeutics
selenium
based
cancer
11. Bandana Chatterjee, Ph.D. (USA) Targeting Intra tumor Androgen Signaling in Prostate Cancer via Enzymatic Sulfation: A Nuclear Receptor-directed Novel Treatment Approach 12. Barbara Dunn, Ph.D. (USA) Update of Clinical Trials in Breast Cancer
TBA
Treatment of GI Cancers
Osteoclastogenic Factors to Prevent Osteolytic Bone Metastasis of Breast Cancer 17. Chandrani Sarkar, Ph.D. (USA) TBA
18. Charles Giardina, Ph.D. (USA) New experimental approaches for identifying novel colon cancer chemopreventive agents
Modulating AKT induced Epithelial Mesenchymal Transition for Prevention and Treatment of Colon Cancer
Molecular analysis of cellular pathways associated with the development of uterine cervical carcinoma
21. Dipak Banerjee, Ph.D. (USA-PR) Tunicamycin Inhibits Angiogenesis and Prevents Breast Cancer Progression
22. Dipak Sarkar, Ph.D. (USA) Current Research Work on Role of beta-endorphin in Cancer Prevention
TBA
24. Ellora Sen, Ph.D. (IND) Tumor necrosis factor (TNFa) regulates radioresistance in glioblastoma
25. Ernest Hawk, MD (USA) Clinical Agent Development for CRC Prevention.
26. Gopal Chakrabarti, Ph.D. (IND) Targeted Drug Development: Synthetic thiadiazole NMK-TD-100, a novel microtubule modulating agent, induces apoptosis and autophagy in cancer cells. 27. Gopal Kundu, Ph.D. (IND) Osteopontin and Related Proteins: Role in Inflammation, Angiogenesis Cancer and Pathological
GhoshChoudhury,
29. Hari Koul, Ph.D. (USA) Sam Pointed Domain Transcription Factor: A New Tumor Metastasis Suppressor
30. Jamboor Vishwanatha, Ph.D. (USA) Reciprocal Regulation of Her-2 and Annexin A2 in Breast Cancer
31. James W. Freeman, Ph.D. (USA) Molecular Targets for Therapy of the in
Cell
Phenotype
32. Joan Cunningham, Ph.D. (USA) Using massage therapy to treat chemotherapyinduced peripheral neuropathy
Progression
34. Kattesh V. Katti, Ph.D. (USA) How can we achieve tumor staurticity of fast growing and inoperable metastatic Cancers
35. Lester F. Lau, Ph.D. (USA) The Matricellular Protein CCN1 in Inflammatory Diseases and Cancer
36. Lucio Miele, MD, Ph.D. (USA) Development of Notch inhibitors in breast cancer: targeting stem cell pathways
37. Mahitosh Mandal (IND) The potential of celecoxib-loaded hydroxyapatitechitosan nanocomposite for the treatment of colon cancer
38. Mausumi Bharadwaj, Ph.D. (IND) The genetic and epigenetic regulation of
39. Michael J. Wargovich, (USA) Epigenetic Mechanisms in the Chemoprevention of Colon Cancer by Tea Polyphenol, EGCG
TBA
41. Mohamed Saleem (Bhat), Ph.D (USA) Strategies to Tame the Activities of Androgen Receptor for Treating Androgen-independent Prostate Cancer
43. Nandini Ghsh-Choudhury ,Ph.D. (USA) Omega 3 Fatty Acids Differentially Target
OncomiRs and Tumor Suppressor micro-RNAs to Prevent Breast Cancer Metastasis 44. Neil Bhowmick, PhD (USA) Targeted therapeutics require tumor microenvironment considerations
TBA
46. Ossama Tawfik, MD, Ph.D. (USA) What Does a Pap Smear Have to do with Telepathology? TelePAPology the New Kid on the Block!!
47. Pamela Munster, MD, Ph.D. (USA) Reversal of hormone therapy resistance by epigenetic modulation
48. Partha P. Majumdar, Ph.D. (IND) GENOMIC ORAL ALTERATIONS IN GINGIVO-BUCCAL BY MASSIVELY-
CANCER,
IDENTIFIED
49. Peeyush Lala, MD, Ph.D (CAN) COX-2 and COX-2 induced miRNAs in breast cancer progression: sustenace of Stem-like cells
50. Peter Van Velduizen, MD (USA) Prostate Cancer: New Paradigms and
51. Prasanta
Banerji
(IND)
and
Pratip The Banerji Protocols: The Regression of Malignant Tumors by a Non-Toxic and Non-Invasive Oral
Medical Approach
52. Priyabrata Mukherjee , Ph.D. (USA) Nanomedicine: Opportunities and Challenges in Cancer Therapy
54. Rajagopal Ramesh, Ph.D. (USA) TUSC2/FUS1-gene-based nanotherapy for lung cancer: From Mice to Humans
55. Rajendra G. Mehta, Ph.D (USA) Deguelin as a possible chemopreventive and therapeutic agent for breast cancer
56. Rajesh Agarwal, Ph.D. (USA) Epigenetic Mechanisms Contributing to the Anticancer Efficacy of Silibinin in Non-small Cell Lung Cancer
Lakshmanaswamy,
Ph.D.
58. Rao Papineni, Ph.D. (USA) Imaging in vivo ROS Activity in Inflammation and Cancer A non invasive approach
59. Ratna Chakrabarti , Ph.D. (USA) Actin cytosketon modulatory protein LIM kinase 1 and functional regulation of MT1-MMP: Implication in invasion of prostate cancer cells 60. Ratna Ray, Ph.D. (USA) Prostate Cancer: Potential for Prevention and Therapy
61. Richard Eckert, Ph.D.(USA) Polycomb Genes, chemoprevention and skin cancer response to cell stress
62. Rita Mulherker, Ph.D. (IND) Gene Therapy for Head and Neck cancer: From lab to Clinics
63. Robert Sclafani, Ph.D. (USA) Molecular Mechanism of Cancer Chemoprevention by Resveratrol.
64. Rod Dashwood (USA) Epigenetics, diet, and cancer: Convergence of histone marks, DNA methylation, and miRNA profiling in chemoprevention studies
65. Roy Jensen, MD (USA) Overcoming BRCA1 Mediated Chemotherapeutic and Radiation Resistance in Cancer
67. Sanjay Gupta, Ph.D. (USA) PLANT FLAVONOIDS AS EPIGENETIC MODULATORS IN CANCER: IMPLICATIONS IN CANCER CHEMOPREVENTION
TBA
TBA
TBA
TBA
TBA
76. Soumen Paul, Ph.D. (USA) Protein Kinase C Signaling: from Embryonic Stem Cell to Cancer
77. Subash Basu ,PhD, D.Sc (USA) Probable New Therapeutic Drugs for Breast and Colon Cancers
78. Subhamoy Dasgupta, PhD (USA) Steroid Receptor Coactivator in Oncogenic Reprogramming of Cancer Cell Metabolism.
TBA
80. Suman Kambhampati, MD (USA) A Second Generation 2-Methoxyestradiol Prodrug is Effective against Barretts Adenocarcinoma in a Mouse Xenograft Model 81. Sushanta K. Banerjee, Ph.D (USA) Aspirin in breast carcinogenesis: A friend or foe
82. Tanya Das, Ph.D (IND) Targeting cancer stem cells: An approach towards next generation cancer therapy
83. Tapan Chaudhuri, MD (USA) Introduction to the science of acupuncture and its application in the realm of Cancer
84. Tapas Kundu, Ph.D (IND) Epigenetic Modifications as Targets of Cancer Therapeutics: Implications in Oral Cancer.
TBA
87. Tony Kong, MD (USA) Cancer Prevention by Dietary Phytochemicals: from Nrf2-mediated Anti-Oxidative Stress, Epigenetics to in vivo Cancer Models
Kelavkar,
89. Urmi Chatterji, Ph.D (IND) Elucidating the molecular signaling adapted by artemisinin in cervical cancer cells
Evaluating
renal
function
in
patients
undergoing chemotherapy
92. Xiaolin Zi , PhD (USA) Epigenetic chemoprevention of tobacco-related urinary bladder carcinogenesis by Kawain
TBA